51
|
Tada H. Thromboembolic Risks That Require Consideration for Antithrombotic Therapy in Japanese Patients With Atrial Fibrillation. Circ J 2014; 78:2373-5. [DOI: 10.1253/circj.cj-14-0914] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Hiroshi Tada
- Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui
| |
Collapse
|
52
|
Okumura K, Inoue H, Atarashi H, Yamashita T, Tomita H, Origasa H, for the J-RHYTHM Registry Investigators.. Validation of CHA 2DS 2-VASc and HAS-BLED Scores in Japanese Patients With Nonvalvular Atrial Fibrillation. Circ J 2014; 78:1593-9. [DOI: 10.1253/circj.cj-14-0144] [Citation(s) in RCA: 83] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Ken Okumura
- Department of Cardiology, Hirosaki University Graduate School of Medicine
| | - Hiroshi Inoue
- Second Department of Internal Medicine, University of Toyama School of Medicine
| | | | | | - Hirofumi Tomita
- Department of Cardiology, Hirosaki University Graduate School of Medicine
| | - Hideki Origasa
- Division of Biostatistics and Clinical Epidemiology, University of Toyama School of Medicine
| | | |
Collapse
|
53
|
Yasaka M. How Should We Apply the CHA 2DS 2-VASc Score to Non-Valvular Atrial Fibrillation Patients in Japan? Circ J 2014; 78:1567-8. [DOI: 10.1253/circj.cj-14-0561] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Masahiro Yasaka
- Department of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Center
| |
Collapse
|